Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Cytotherapy ; 26(7): 769-777, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38556961

ABSTRACT

BACKGROUND AIMS: The administration of human cell-processed therapeutic products (hCTPs) is associated with a risk of tumorigenesis due to the transformed cellular contaminants. To mitigate this risk, these impurities should be detected using sensitive and validated assays. The digital soft agar colony formation (D-SAC) assay is an ultrasensitive in vitro test for detecting tumorigenic transformed cells in hCTPs. METHODS: In this study, we first evaluated the colony formation efficiency (CFE) precision of tumorigenic reference cells in positive control samples according to a previously reported D-SAC assay protocol (Protocol I) from multiple laboratories. However, the CFE varied widely among laboratories. Thus, we improved and optimized the test protocol as Protocol II to reduce variability in the CFE of tumorigenic reference cells. Subsequently, the improved protocol was validated at multiple sites. Human mesenchymal stromal cells (hMSCs) were used as model cells, and positive control samples were prepared by spiking them with HeLa cells. RESULTS: Based on the previously reported protocol, the CFE was estimated using an ultra-low concentration (0.0001%) of positive control samples in multiple plates. Next, we improved the protocol to reduce the CFE variability. Based on the CFE results, we estimated the sample size as the number of wells (Protocol II) and assessed the detectability of 0.0001% HeLa cells in hMSCs to validate the protocol at multiple sites. Using Protocol I yielded low CFEs (mean: 30%) and high variability between laboratories (reproducibility coefficient of variance [CV]: 72%). In contrast, Protocol II, which incorporated a relatively high concentration (0.002%) of HeLa cells in the positive control samples, resulted in higher CFE values (mean: 63%) and lower variability (reproducibility CV: 18%). Moreover, the sample sizes for testing were estimated as the number of wells per laboratory (314-570 wells) based on the laboratory-specific CFE (42-76%). Under these conditions, all laboratories achieved a detection limit of 0.0001% HeLa cells in hMSCs in a predetermined number of wells. Moreover, colony formation was not observed in the wells seeded with hMSCs alone. CONCLUSIONS: The D-SAC assay is a highly sensitive and robust test for detecting malignant cells as impurities in hCTPs. In addition, optimal assay conditions were established to test tumorigenic impurities in hCTPs with high sensitivity and an arbitrary false negative rate.


Subject(s)
Cell- and Tissue-Based Therapy , Mesenchymal Stem Cells , Humans , HeLa Cells , Cell- and Tissue-Based Therapy/methods , Mesenchymal Stem Cells/cytology , Cell Transformation, Neoplastic
2.
Regul Toxicol Pharmacol ; 117: 104756, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32822771

ABSTRACT

Human stem cell-derived cardiomyocytes (hSC-CMs) hold great promise as in vitro models to study the electrophysiological effects of novel drug candidates on human ventricular repolarization. Two recent large validation studies have demonstrated the ability of hSC-CMs to detect drug-induced delayed repolarization and "cellrhythmias" (interrupted repolarization or irregular spontaneous beating of myocytes) linked to Torsade-de-Pointes proarrhythmic risk. These (and other) studies have also revealed variability of electrophysiological responses attributable to differences in experimental approaches and experimenter, protocols, technology platforms used, and pharmacologic sensitivity of different human-derived models. Thus, when evaluating drug-induced repolarization effects, there is a need to consider 1) the advantages and disadvantages of different approaches, 2) the need for robust functional characterization of hSC-CM preparations to define "fit for purpose" applications, and 3) adopting standardized best practices to guide future studies with evolving hSC-CM preparations. Examples provided and suggested best practices are instructional in defining consistent, reproducible, and interpretable "fit for purpose" hSC-CM-based applications. Implementation of best practices should enhance the clinical translation of hSC-CM-based cell and tissue preparations in drug safety evaluations and support their growing role in regulatory filings.


Subject(s)
Adult Stem Cells/drug effects , Arrhythmias, Cardiac/chemically induced , Cardiotoxins/toxicity , Myocytes, Cardiac/drug effects , Practice Guidelines as Topic/standards , Validation Studies as Topic , Adult Stem Cells/pathology , Adult Stem Cells/physiology , Arrhythmias, Cardiac/pathology , Arrhythmias, Cardiac/physiopathology , Humans , Membrane Potentials/drug effects , Membrane Potentials/physiology , Myocytes, Cardiac/pathology
3.
J Pharmacol Sci ; 138(4): 233-239, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30415824

ABSTRACT

Cardiac safety assessment is challenging because a better understanding of torsadogenic mechanisms beyond hERG blockade and QT interval prolongation is necessary for patient safety. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) provide a new human cell-based platform to assess cardiac safety in non-clinical testing during drug development. The multi-electrode array (MEA) platform is a promising electrophysiological technology to assess QT interval prolongation and proarrhythmic potential of drug candidates using hiPSC-CMs. The Japan iPS Cardiac Safety Assessment (JiCSA) has established an MEA protocol to evaluate the applicability of hiPSC-CMs for assessing the torsadogenic potential of compounds and completed a large-scale validation study using 60 compounds. During our study, an international multi-site study of hiPSC-CMs was performed by the Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative using 28 compounds. We have comparatively analyzed our JiCSA datasets with those of CiPA using the CiPA logistical and ordinal linear regression model. Regardless of the protocol differences, the evaluation results of the 28 compounds were very similar and highly predictable for torsadogenic risks. Thus, an MEA-based approach using hiPSC-CMs would be a standard testing method to evaluate proarrhythmic potentials. This review paper would provide new insights into the hiPSC-CMs/MEA method required for its regulatory use.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Induced Pluripotent Stem Cells/cytology , Myocytes, Cardiac/drug effects , Torsades de Pointes/chemically induced , Biological Assay , Humans , Myocytes, Cardiac/physiology , Risk Assessment
4.
Biochem Biophys Res Commun ; 434(1): 15-21, 2013 Apr 26.
Article in English | MEDLINE | ID: mdl-23548571

ABSTRACT

We examined the roles of poly(ADP-ribosylation) in chromatin remodeling during the first cell cycle of mouse embryos. Drug-based inhibition of poly(ADP-ribosylation) by a PARP inhibitor, PJ-34, revealed up-regulation of dimethylation of histone H3 at lysine 4 in male pronuclei and down-regulation of dimethylation of histone H3 at lysine 9 (H3K9) and lysine 27 (H3K27). Association of poly(ADP-ribosylation) with histone modification was suggested to be supported by the interaction of Suz12, a histone methyltransferase in the polycomb complex, with Parp1. PARP activity was suggested to be required for a proper localization and maintenance of Suz12 on chromosomes. Notably, DNA methylation level of female pronuclei in one-cell embryos was robustly decreased by PJ-34. Electron microscopic analysis showed a frequent appearance of unusual electron-dense areas within the female pronuclei, implying the disorganized and hypercondensed chromatin ultrastructure. These results show that poly(ADP-ribosylation) is important for the integrity of non-equivalent epigenetic dynamics of pronuclei during the first cell cycle of mouse embryos.


Subject(s)
Cell Cycle/drug effects , Chromatin/metabolism , Histones/metabolism , Poly Adenosine Diphosphate Ribose/metabolism , Animals , DNA Methylation/drug effects , Female , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Phenanthrenes/pharmacology , Poly (ADP-Ribose) Polymerase-1 , Poly Adenosine Diphosphate Ribose/antagonists & inhibitors , Poly Adenosine Diphosphate Ribose/physiology , Poly(ADP-ribose) Polymerase Inhibitors , Poly(ADP-ribose) Polymerases/deficiency , Poly(ADP-ribose) Polymerases/genetics
5.
Cell Rep ; 24(13): 3582-3592, 2018 09 25.
Article in English | MEDLINE | ID: mdl-30257217

ABSTRACT

To assess the utility of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as an in vitro proarrhythmia model, we evaluated the concentration dependence and sources of variability of electrophysiologic responses to 28 drugs linked to low, intermediate, and high torsades de pointes (TdP) risk categories using two commercial cell lines and standardized protocols in a blinded multisite study using multielectrode array or voltage-sensing optical approaches. Logistical and ordinal linear regression models were constructed using drug responses as predictors and TdP risk categories as outcomes. Three of seven predictors (drug-induced arrhythmia-like events and prolongation of repolarization at either maximum tested or maximal clinical exposures) categorized drugs with reasonable accuracy (area under the curve values of receiver operator curves ∼0.8). hiPSC-CM line, test site, and platform had minimal influence on drug categorization. These results demonstrate the utility of hiPSC-CMs to detect drug-induced proarrhythmic effects as part of the evolving Comprehensive In Vitro Proarrhythmia Assay paradigm.


Subject(s)
Drug Evaluation, Preclinical/methods , Electrophysiology/methods , Induced Pluripotent Stem Cells/cytology , Myocytes, Cardiac/drug effects , Torsades de Pointes/chemically induced , Cardiotoxicity , Cell Line , Cellular Reprogramming , Drug Evaluation, Preclinical/standards , Electrophysiology/standards , Humans , Membrane Potentials/drug effects , Myocytes, Cardiac/cytology , Myocytes, Cardiac/physiology
6.
J Pharmacol Toxicol Methods ; 84: 111-127, 2017.
Article in English | MEDLINE | ID: mdl-27956204

ABSTRACT

INTRODUCTION: Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are anticipated to be a useful tool for conducting proarrhythmia risk assessments of drug candidates. However, a torsadogenic risk prediction paradigm using hiPSC-CMs has not yet been fully established. METHODS: Extracellular field potentials (FPs) were recorded from hiPSC-CMs using the multi-electrode array (MEA) system. The effects on FPs were evaluated with 60 drugs, including 57 with various clinical torsadogenic risks. Actual drug concentrations in medium were measured using the equilibrium dialysis method with a Rapid Equilibrium Dialysis device. Relative torsade de pointes (TdP) scores were determined for each drug according to the degree of FP duration prolongation and early afterdepolarization occurrence. The margins were calculated from the free concentration in medium and free effective therapeutic plasma concentration. Each drug's results were plotted on a two-dimensional map of relative TdP risk scores versus margins. RESULTS: Each drug was categorised as high, intermediate, or low risk based on its location within predefined areas of the two-dimensional map. We categorised 19 drugs as high risk; 18 as intermediate risk; and 17 as low risk. We examined the concordance between our categorisation of high and low risk drugs against the torsadogenic risk categorisation in CredibleMeds®. Our system demonstrated high concordance, as reflected in a sensitivity of 81%, specificity of 87%, and accuracy of 83%. DISCUSSION: These results indicate that our torsadogenic risk assessment is reliable and has a potential to replace the hERG assay for torsadogenic risk prediction, however, this system needs to be improved for the accurate of prediction of clinical TdP risk. Here, we propose a novel drug induced torsadogenic risk categorising system using hiPSC-CMs and the MEA system.


Subject(s)
Action Potentials/drug effects , Cardiotoxins/toxicity , Induced Pluripotent Stem Cells/drug effects , Myocytes, Cardiac/drug effects , Torsades de Pointes/chemically induced , Action Potentials/physiology , Cells, Cultured , Humans , Induced Pluripotent Stem Cells/physiology , Myocytes, Cardiac/physiology , Risk Assessment , Torsades de Pointes/pathology , Torsades de Pointes/physiopathology
7.
J Neurosci ; 25(37): 8368-74, 2005 Sep 14.
Article in English | MEDLINE | ID: mdl-16162918

ABSTRACT

Nuclei isolated from green fluorescent protein-marked neurons in the cerebral cortex of juvenile mice (14-21 d after birth) were injected into enucleated oocytes that were allowed to develop into blastocysts. Embryonic stem (ES) cell lines were established from the inner cell mass of 76 cloned blastocysts after injecting 2026 neuronal nuclei. Some ES cells were injected individually into enucleated oocytes (nuclear transfer). Other ES cells were transferred into the blastocoeles of tetraploid blastocysts (tetraploid complementation). Two-cell embryos after nuclear transfer were transferred to the oviducts of surrogate mothers. Four (1.5%) of 272 nuclear-transferred two-cell embryos developed to term, and two (0.7%) developed into fertile adults. Nineteen (1.9%) of 992 tetraploid blastocysts receiving ES cells reached term, and 10 (1.0%) developed into adults. These findings demonstrate that some of the nuclei of differentiated neurons in the cerebral cortex of juvenile mice maintain developmental pluripotency.


Subject(s)
Cell Nucleus/physiology , Cell Nucleus/ultrastructure , Cerebral Cortex/physiology , Neurons/cytology , Neurons/physiology , Animals , Blastocyst/physiology , Cerebral Cortex/embryology , Cloning, Organism , Embryo, Mammalian , Genetic Markers , Genetic Vectors , Green Fluorescent Proteins/analysis , Green Fluorescent Proteins/genetics , Mice , Plasmids , Polyploidy , Stem Cells/cytology , Stem Cells/physiology
8.
Curr Protein Pept Sci ; 17(7): 693-704, 2016.
Article in English | MEDLINE | ID: mdl-27090907

ABSTRACT

Accumulating evidence suggests that cloned mice production by the injection of a somatic cell nucleus into an enucleated oocyte is inefficient. DNA damage and chromatin remodeling failures that occur during embryogenesis following nuclear transfer (NT) might explain the poor development of cloned embryos. To avoid these problems, it is important to elucidate somatic chromatin remodeling after NT. Because polyADP-ribosylation, which is catalyzed mainly by poly(ADP-ribose) polymerase 1 (Parp1), is a major post-translational modification that facilitates DNA repair and chromatin remodeling, we examined the effects of Parp1 deficiency in developing NT embryos. Parp1 was located within the pseudo-pronuclei (PPN) of NT eggs. We observed that NT eggs, after activation by Sr2+, formed PPN with significantly more efficiency in Parp1-null embryos than in wild-type NT embryos. However, most the Parp1-null embryos stopped developing by the four-cell stage. Immunostaining for γH2AX foci, a marker of DNA double strand breaks, showed longer retention in the PPN of Parp1-/- donor NT embryos than in wild-type NT embryos, suggesting that, in the absence of Parp1, DNA breaks are slowly repaired and consequently, entry into the S phase might be delayed. Furthermore, decreases in histone H3 acetylation, H3 monomethylation at lysine 4, and H3 trimethylation at lysine 27 after the Sr2+ activation step were observed in the PPN of Parp1-/- donor embryos. Taken together, our data suggest that Parp1 is involved in the plastic remodeling of chromatin structure after NT by supporting DNA repair and specific histone code modifications.


Subject(s)
Cellular Reprogramming/genetics , Chromatin Assembly and Disassembly/genetics , Chromatin/genetics , Chromatin/metabolism , Nuclear Transfer Techniques , Poly (ADP-Ribose) Polymerase-1/deficiency , Acetylation , Animals , Cell Cycle Checkpoints/genetics , Embryo Research , Female , Histones/metabolism , Immunohistochemistry , Male , Methylation , Mice , Mice, Knockout , Mitosis/genetics , Mutation , Poly (ADP-Ribose) Polymerase-1/genetics , Poly (ADP-Ribose) Polymerase-1/metabolism , Protein Transport
9.
PLoS One ; 11(12): e0167348, 2016.
Article in English | MEDLINE | ID: mdl-27923051

ABSTRACT

The aims of this study were to (1) characterize basic electrophysiological elements of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) that correspond to clinical properties such as QT-RR relationship, (2) determine the applicability of QT correction and analysis methods, and (3) determine if and how these in-vitro parameters could be used in risk assessment for adverse drug-induced effects such as Torsades de pointes (TdP). Field potential recordings were obtained from commercially available hiPSC-CMs using multi-electrode array (MEA) platform with and without ion channel antagonists in the recording solution. Under control conditions, MEA-measured interspike interval and field potential duration (FPD) ranged widely from 1049 to 1635 ms and from 334 to 527 ms, respectively and provided positive linear regression coefficients similar to native QT-RR plots obtained from human electrocardiogram (ECG) analyses in the ongoing cardiovascular-based Framingham Heart Study. Similar to minimizing the effect of heart rate on the QT interval, Fridericia's and Bazett's corrections reduced the influence of beat rate on hiPSC-CM FPD. In the presence of E-4031 and cisapride, inhibitors of the rapid delayed rectifier potassium current, hiPSC-CMs showed reverse use-dependent FPD prolongation. Categorical analysis, which is usually applied to clinical QT studies, was applicable to hiPSC-CMs for evaluating torsadogenic risks with FPD and/or corrected FPD. Together, this results of this study links hiPSC-CM electrophysiological endpoints to native ECG endpoints, demonstrates the appropriateness of clinical analytical practices as applied to hiPSC-CMs, and suggests that hiPSC-CMs are a reliable models for assessing the arrhythmogenic potential of drug candidates in human.


Subject(s)
Chromans/pharmacology , Cisapride/pharmacology , Induced Pluripotent Stem Cells/physiology , Myocytes, Cardiac/cytology , Piperidines/pharmacology , Pyridines/pharmacology , Sulfonamides/pharmacology , Cells, Cultured , Electrophysiological Phenomena/drug effects , Heart Rate/drug effects , Humans , Induced Pluripotent Stem Cells/cytology , Induced Pluripotent Stem Cells/drug effects , Linear Models , Models, Cardiovascular , Torsades de Pointes/chemically induced , Torsades de Pointes/physiopathology
10.
Cloning Stem Cells ; 7(1): 45-61, 2005.
Article in English | MEDLINE | ID: mdl-15996117

ABSTRACT

Cloning of mice has been achieved by transferring nuclei of various types of somatic cell nuclei into enucleated oocytes. However, all attempts to produce live cloned offspring using the nuclei of neurons from adult cerebral cortex have failed. Previously we obtained cloned mice using the nuclei of neural cells collected from fetal cerebral cortex. Here, we attempted to generate cloned mice using differentiated neurons from the cerebral cortex of postnatal (day 0-4) mice. Although we were unable to obtain live cloned pups, many fetuses reached day 10.5 days of development. These fetuses showed various abnormalities such as spherical omission of the neuroepithelium, collapsed lumen of neural tube, and aberrant expressions of marker proteins of neurons. We produced chimeric mice in which some hair cells and kidney cells were originated from differentiated neurons. In chimeric fetuses, LacZ-positive donor cells were in all three germ cell layers. However, chimeras with large contribution of donor-derived cells were not obtained. These results indicate that nuclei of differentiated neurons have lost their developmental totipotency. In other words, the conventional nuclear transfer technique does not allow nuclei of differentiated neurons to undergo complete genomic reprogramming required for normal embryonic development.


Subject(s)
Cerebral Cortex/cytology , Cloning, Organism/methods , Neurons/cytology , Animals , Cell Nucleus/metabolism , Chimera , Embryo, Mammalian/metabolism , Embryonic Development , Female , Galactosides/pharmacology , Immunohistochemistry , Indoles/pharmacology , Lac Operon , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Microscopy, Fluorescence , Neural Crest/cytology , Neurons/metabolism , Oocytes/metabolism , Time Factors
11.
Article in English | MEDLINE | ID: mdl-25910965

ABSTRACT

INTRODUCTION: Multi-electrode array (MEA) systems and human induced pluripotent stem (iPS) cell-derived cardiomyocytes are frequently used to characterize the electrophysiological effects of drug candidates for the prediction of QT prolongation and proarrhythmic potential. However, the optimal experimental conditions for obtaining reliable experimental data, such as high-pass filter (HPF) frequency and cell plating density, remain to be determined. METHODS: Extracellular field potentials (FPs) were recorded from iPS cell-derived cardiomyocyte sheets by using the MED64 and MEA2100 multi-electrode array systems. Effects of HPF frequency (0.1 or 1Hz) on FP duration (FPD) were assessed in the presence and absence of moxifloxacin, terfenadine, and aspirin. The influence of cell density on FP characteristics recorded through a 0.1-Hz HPF was examined. The relationship between FP and action potential (AP) was elucidated by simultaneous recording of FP and AP using a membrane potential dye. RESULTS: Many of the FP waveforms recorded through a 1-Hz HPF were markedly deformed and appeared differentiated compared with those recorded through a 0.1-Hz HPF. The concentration-response curves for FPD in the presence of terfenadine reached a steady state at concentrations of 0.1 and 0.3µM when a 0.1-Hz HPF was used. In contrast, FPD decreased at a concentration of 0.3µM with a characteristic bell-shaped concentration-response curve when a 1-Hz HPF was used. The amplitude of the first and second peaks in the FP waveform increased with increasing cell plating density. The second peak of the FP waveform roughly coincided with AP signal at 50% repolarization, and the negative deflection at the second peak of the FP waveform in the presence of E-4031 corresponded to early afterdepolarization and triggered activity. DISCUSSION: FP can be used to assess the QT prolongation and proarrhythmic potential of drug candidates; however, experimental conditions such as HPF frequency are important for obtaining reliable data.


Subject(s)
Arrhythmias, Cardiac/chemically induced , Induced Pluripotent Stem Cells/cytology , Long QT Syndrome/chemically induced , Myocytes, Cardiac/drug effects , Action Potentials/drug effects , Arrhythmias, Cardiac/diagnosis , Aspirin/administration & dosage , Aspirin/toxicity , Dose-Response Relationship, Drug , Fluoroquinolones/administration & dosage , Fluoroquinolones/toxicity , Humans , Long QT Syndrome/diagnosis , Moxifloxacin , Piperidines/administration & dosage , Piperidines/toxicity , Pyridines/administration & dosage , Pyridines/toxicity , Terfenadine/administration & dosage , Terfenadine/toxicity
12.
Biotechnol Prog ; 30(6): 1401-10, 2014.
Article in English | MEDLINE | ID: mdl-25078970

ABSTRACT

Oxygen supply is a critical issue in the optimization of in vitro hepatocyte microenvironments. Although several strategies have been developed to balance complex oxygen requirements, these techniques are not able to accurately meet the cellular oxygen demand. Indeed, neither the actual oxygen concentration encountered by cells nor the cellular oxygen consumption rates (OCR) was assessed. The aim of this study is to define appropriate oxygen conditions at the cell level that could accurately match the OCR and allow hepatocytes to maintain liver specific functions in a normoxic environment. Matrigel overlaid rat hepatocytes were cultured on the polydimethylsiloxane (PDMS) membranes under either atmospheric oxygen concentration [20%-O2 (+)] or physiological oxygen concentrations [10%-O2 (+), 5%-O2 (+)], respectively, to investigate the effects of various oxygen concentrations on the efficient functioning of hepatocytes. In parallel, the gas-impermeable cultures (polystyrene) with PDMS membrane inserts were used as the control groups [PS-O2 (-)]. The results indicated that the hepatocytes under 10%-O2 (+) exhibited improved survival and maintenance of metabolic activities and functional polarization. The dramatic elevation of cellular OCR up to the in vivo liver rate proposed a normoxic environment for hepatocytes, especially when comparing with PS-O2 (-) cultures, in which the cells generally tolerated hypoxia. Additionally, the expression levels of 84 drug-metabolism genes were the closest to physiological levels. In conclusion, this study clearly shows the benefit of long-term culture of hepatocytes at physiological oxygen concentration, and indicates on an oxygen-permeable membrane system to provide a simple method for in vitro studies.


Subject(s)
Cell Culture Techniques/instrumentation , Cell Culture Techniques/methods , Hepatocytes/cytology , Hepatocytes/metabolism , Membranes, Artificial , Oxygen/metabolism , Albumins/metabolism , Animals , Aryl Hydrocarbon Hydroxylases/metabolism , Bile Canaliculi/cytology , Bile Canaliculi/physiology , Cell Survival , Dimethylpolysiloxanes , Male , Oxygen/analysis , Rats , Rats, Wistar , Tissue Engineering
13.
Lab Chip ; 12(10): 1857-64, 2012 Apr 24.
Article in English | MEDLINE | ID: mdl-22441571

ABSTRACT

Analysis of biliary metabolites is essential to predict pharmacokinetics and hepatotoxicity during drug development. In this paper, we present a hepatocyte culture configuration that enables the direct recovery of bile acid that accumulates in bile canaliculi by embedding the hepatocytes in a 3D micropatterned collagen gel substrate. We investigated the formation of bile canaliculi in hepatocytes embedded in circular microcavities of various sizes and made from collagen gel. Image analyses using fluorescently labeled bile acid revealed that the area of bile canaliculi in embedded hepatocytes in a microcavity of 60 or 80 µm in diameter was enlarged when compared with other sized microcavities and those of hepatocytes cultured using conventional hepatocyte sandwich cultures. We successfully recovered bile acid from the enlarged bile canaliculi of hepatocytes cultured in microcavities using a glass capillary and quantified the amount recovered. Using our approach, the direct recovery of biliary metabolites, using hepatocyte cultures with enhanced biliary excretion and geometrically enlarged bile canaliculi, may enable accurate screening of pharmacokinetics and drug-drug interactions against drug transporters.


Subject(s)
Bile Acids and Salts/metabolism , Bile Canaliculi/metabolism , Bile/metabolism , Cell Culture Techniques/instrumentation , Cell Culture Techniques/methods , Hepatocytes/metabolism , ATP-Binding Cassette Transporters/metabolism , Animals , Cells, Cultured , Cholic Acids/metabolism , Collagen/chemistry , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Image Processing, Computer-Assisted , Male , Microscopy, Fluorescence , Particle Size , Rats , Rats, Wistar
14.
PLoS One ; 5(9)2010 Sep 02.
Article in English | MEDLINE | ID: mdl-20824066

ABSTRACT

BACKGROUND: During fertilization, pronuclear envelope breakdown (PNEB) is followed by the mingling of male and female genomes. Dynamic chromatin and protein rearrangements require posttranslational modification (PTM) for the postfertilization development. METHODOLOGY/PRINCIPAL FINDINGS: Inhibition of poly(ADP-ribose) polymerase activity (PARylation) by either PJ-34 or 5-AIQ resulted in developmental arrest of fertilized embryos at the PNEB. PARylation inhibition affects spindle bundle formation and phosphorylation of Erk molecules of metaphase II (MII) unfertilized oocytes. We found a frequent appearance of multiple pronuclei (PN) in the PARylation-inhibited embryos, suggesting defective polymerization of tubulins. Attenuated phosphorylation of lamin A/C by PARylation was detected in the PARylation-inhibited embryos at PNEB. This was associated with sustained localization of heterodomain protein 1 (HP1) at the PN of the one-cell embryos arrested by PARylation inhibition. CONCLUSIONS/SIGNIFICANCE: Our findings indicate that PARylation is required for pronuclear fusion during postfertilization processes. These data further suggest that PARylation regulates protein dynamics essential for the beginning of mouse zygotic development. PARylation and its involving signal-pathways may represent potential targets as contraceptives.


Subject(s)
Cell Nucleus Division , Cell Nucleus/metabolism , Fertilization , Poly Adenosine Diphosphate Ribose/metabolism , Animals , Cell Nucleus/genetics , Female , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Poly(ADP-ribose) Polymerases/metabolism , Zygote/cytology , Zygote/metabolism
15.
Mol Reprod Dev ; 72(3): 329-35, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16047391

ABSTRACT

We have developed a mouse transgenesis technique that facilitates the insertion of large (approximately 200 kilo base pairs) DNA fragments into host genomes of both inbred and hybrid mice. Six inbred and three hybrid transgenic mice carrying a single bacterial artificial chromosome (BAC) clone with genes located in the Down syndrome critical region of human chromosome 21 were produced using this technology.


Subject(s)
Chromosomes, Artificial, Bacterial/genetics , Chromosomes, Human, Pair 21/genetics , Down Syndrome/genetics , Gene Transfer Techniques , Sperm Injections, Intracytoplasmic/methods , Animals , Blotting, Southern , DNA Primers , Dithiothreitol , Embryo Transfer , Female , Humans , Male , Mice , Mice, Transgenic
SELECTION OF CITATIONS
SEARCH DETAIL